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Abstract
Background: Considerable debate exists concerning the effects of antiretroviral therapy (ART) service scale-up on
non-HIV services and overall health system performance in sub-Saharan Africa. In this study, we examined whether
ART services affected trends in non-ART outpatient department (OPD) visits in Kenya and Uganda.
Methods: Using a nationally representative sample of health facilities in Kenya and Uganda, we estimated the
effect of ART programs on OPD visits from 2007 to 2012. We modeled the annual percent change in non-ART OPD
visits using hierarchical mixed-effects linear regressions, controlling for a range of facility characteristics. We used
four different constructs of ART services to capture the different ways in which the presence, growth, overall, and
relative size of ART programs may affect non-ART OPD services.
Results: Our final sample included 321 health facilities (140 in Kenya and 181 in Uganda). On average, OPD and
ART visits increased steadily in Kenya and Uganda between 2007 and 2012. For facilities where ART services were
not offered, the average annual increase in OPD visits was 4·2% in Kenya and 13·5% in Uganda. Among facilities
that provided ART services, we found average annual OPD volume increases of 7·2% in Kenya and 5·6% in Uganda,
with simultaneous annual increases of 13·7% and 12·5% in ART volumes. We did not find a statistically significant
relationship between annual changes in OPD services and the presence, growth, overall, or relative size of ART
services. However, in a subgroup analysis, we found that Ugandan hospitals that offered ART services had
statistically significantly less growth in OPD visits than Ugandan hospitals that did not provide ART services.
Conclusions: Our findings suggest that ART services in Kenya and Uganda did not have a statistically significant
deleterious effects on OPD services between 2007 and 2012, although subgroup analyses indicate variation by
facility type. Our findings are encouraging, particularly given recent recommendations for universal access to ART,
demonstrating that expanding ART services is not inherently linked to declines in other health services in sub-
Saharan Africa.
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Background
HIV/AIDS has been a leading cause of death and disability
in sub-Saharan Africa since the mid-1990s [1]. However,
due to an unprecedented global response, the rate of new
HIV infections has declined and an estimated 19·1 million
life-years have been saved by interventions such as anti-
retroviral therapy (ART) [2]. Such gains have been driven
by a rapid increase in HIV-specific development assistance
for health (DAH), which rose in real terms from $1·4 bil-
lion in 2000 to $11 billion in 2015 [3]. Access to and en-
rollment in ART programs markedly increased in the last
decade, [1, 4] providing life-saving treatment for people
living with HIV throughout the world. Yet amid this suc-
cess, considerable debate exists about how this massive
scale-up of ART has affected the provision of non-HIV
services [5–7]. With HIV-targeted DAH stagnating since
2010 [3] and new treatment guidelines recommending
universal access to ART, [8] understanding if and where
the scale-up of ART services has had beneficial or detri-
mental health system effects is critical.
Previous studies provide conflicting evidence on how the
scale-up of ART has affected health systems in sub-Saharan
Africa. Many argue that the scale-up of ART strengthened
overall health system capacity by increasing resource avail-
ability at health facilities, improving supply chains and bol-
stering support for human resources [9–12]. By contrast,
other studies have found that scarce resources were
diverted away from other health needs and toward largely
vertical HIV treatment programs [7, 13, 14]. Most com-
monly, these findings focused on human resources for
health (HRH), [15–17] documenting substantial employee
shifts from public facilities to non-governmental organiza-
tions (NGOs) and HIV-focused treatment programs due to
higher wages, greater prestige, and the opportunity to pro-
vide improved medical care [17–20].
Mixed results from existing research suggest there
may be a complex interplay between HIV and non-
HIV services. For instance, volumes of maternal and
reproductive health services such as family planning
and antenatal care increased amid rising ART vol-
umes in Zambia, but immunization services experi-
enced fewer gains at facilities providing ART services
[21]. Similarly, HIV funding was correlated with gains
in maternal services such as prenatal blood testing,
but decreases in immunization rates in sub-Saharan
Africa [15]. Among rural health centers in Rwanda,
the provision of HIV services appeared to have little
effect on other patient services, [22] while one study
in Uganda noted that facilities with funding from the
US President’s Emergency Plan for AIDS Relief (PEP-
FAR) was associated with an increased number of de-
liveries [23]. Another recent paper analyzing the
effect of PEPFAR investments on non-HIV services at
the district-level in Uganda found that high PEPFAR
investment was associated with small declines in sev-
eral non-HIV outputs such as pediatric outpatient
visits, TB tests, and inpatient deliveries [24].
In this study, we further examine the interaction be-
tween facility-based ART and non-ART outpatient depart-
ment (OPD) services, filling an important information gap
for key stakeholders as they develop policies aimed at
reaching universal ART coverage. Drawing from unique,
nationally-representative facility datasets in Kenya and
Uganda, two countries with significant HIV epidemics, we
assess trends in ART and non-ART OPD services at the
country level and across facility types from 2007 to 2012.
Specifically, we examine the impact of facility-based ART
services on the utilization of non-ART OPD services, and
investigate how various factors, such as facility location
and ownership, influence this relationship.
Methods
Facility sample and instrument
Our study used facility-level data collected in Kenya and
Uganda as part of the Access, Bottlenecks, Costs and
Equity (ABCE) project. For each country, nationally-
representative facility samples were constructed using a
two-step, stratified random sampling process detailed
elsewhere [25, 26]. The sample included publicly- and
privately-owned facilities across all levels of care.
Each facility completed the six-part ABCE Facility Sur-
vey. This survey included cross-sectional data on facility
characteristics, equipment availability, and pharmaceut-
ical stocks. It also requested retrospective longitudinal
data (obtained from facility registries) on the number of
pre-ART, ART, and OPD visits for the last five fiscal
years. Facility data collection took place between April
and November 2012 using DatStat Illume Survey Man-
ager 5.1 (DatStat Inc., Seattle WA).
Definition of key variables
The two key variables used for this analysis were ART
visits and OPD visits. For the purposes of this analysis,
pre-ART visits were included with ART visits as they
were most commonly seen within the ART clinic, utilis-
ing the same ART resources and staff. From this point
forward, “ART visits” refers to the sum of ART and pre-
ART visits, unless otherwise indicated. OPD visits ex-
cluded any ART and pre-ART visits, making the ART
and OPD visit variables mutually exclusive. We included
both adult and child visits for both ART and OPD.
Analysis
For the purpose of this analysis, we used each country’s
health system structure to categorize facilities into hospitals
and health centers/primary care facilities; here we refer to
the latter facilities as health centers for brevity. The hospital
category included sub-district, district, provincial, private
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hospitals, and nursing homes in Kenya, and district, re-
gional referral, and private hospitals in Uganda. The health
center category included health centers, health posts,
clinics, and dispensaries in Kenya, and health center IIs,
health center IIIs, and health center IVs in Uganda. We ex-
cluded national referral hospitals, stand-alone laboratories,
pharmacies, and voluntary counseling and testing (VCT)
centers given their differences in operational capacities and
production processes.
After processing the data to identify and address data
entry errors, less than 15% of annual ART and OPD vol-
umes included in this analysis were missing. These values,
as well as other key missing variables of interest, were im-
puted with Amelia II in R, [27] using lags and leads of two
years. We ran this model 50 times, and used the median
values across these 50 imputations to generate the de-
scriptive statistics presented below. We excluded facilities
with fewer than two years of reported data for OPD visits
or ART visits from our analysis.
For each facility-year (t), we calculated the annual percent
change relative to the previous year (visitst−visitst−1visitst−1  100) for
both ART and OPD visits. We used these results to esti-
mate the average annual percent change in ART and OPD
visits across sampled hospitals and health centres in each
country. We chose to use a weighted average based on the
patient volume in year t-1 to control for undue influence of
smaller facilities.
In our primary analysis, we used a mixed-effects re-
gression model to assess the impact of ART service
provision on OPD visits, controlling for facility charac-
teristics. To account for health system differences, we
chose to model each country separately. In addition,
within each country we performed a subgroup analysis,
modeling hospitals and health centers independently, to
capture differences in service complexity. Our
dependent variable was defined as the annual percent
change in OPD visit volume relative to the previous
year. For both the primary and subgroup analyses, we
ran four different iterations of our model, capturing dif-
ferent aspects of the potential impact of an ART pro-
gram on non-ART OPD services (Table 1).
We specified the following hierarchical model:
Y t;j;i ¼ β0 þ β1 ARTt;ji þ C Xi;j þ β2 t þ γ j;i þ δj
þ εt;j;i
where Y is the annual percent change in OPD visits for
facility i and calendar year t (relative to year t − 1) in dis-
trict or county j; ART is one of the four variables de-
scribed above (Table 1) to characterize the ART
program for facility f and calendar year t; X is a vector of
covariates including facility-type used in the sampling
procedure, facility ownership (public or private/NGO),
and location (urban or rural) for facility i; β2is a fixed
effect for calendar year t; γ is a random effect for facility
i; and δ is a random effect for district (Uganda) or
county (Kenya) j. For facilities that started providing
ART during the panel, the year they started providing
ART was dropped from the analysis when analyzing per-
cent change, given that percent change from zero is un-
defined. In the analysis of all facilities using the binary
indicator of the presence of an ART program, we in-
clude facility and district weights in our analysis. In our
specification of the above model, we nested facility-years
within facilities and facilities within districts or counties.
For all models we used robust standard errors.
All analyses were run in Stata version 13·0 (Stata-
Corp, College Station, Texas) using the MI commands
using datasets generated by the Amelia imputation.
Results
Sample description
Our final sample included 321 health facilities (140 in
Kenya and 181 in Uganda), and a total of 1544
facility-years (666 in Kenya and 878 in Uganda). This
included 26 health facilities that opened and 19 facil-
ities that began offering ART services during the
study period.
Table 2 provides an overview of health facility character-
istics stratified by country, facility type, and the availability
of ART services at the time of survey administration. In
both Kenya and Uganda, a greater percentage of facilities
that provided ART services were publicly owned. Facilities
that provided ART services were also substantially larger
than those facilities that did not provide ART services,
even within the same facility type strata. Not surprisingly,
this often translated to additional services, particularly at
health centers, including increased laboratory capacity
and outreach programs. Across both countries and facil-
ity types, health facilities that offered ART programs saw,
on average, more patients per day in their OPD clinics
than ART clinics.
Table 1 Definition of ART program characteristic variables
included in regression analyses
Variable Definition
ART program
presence
Binary indicator reflecting the presence (or absence)
of an ART program in a given facility-year.
Overall ART
program size
Facility’s total number of pre-ART visits and ART visits
(included as the logged number of visits) as an indi-
cator of ART program size for a given facility-year.
Relative ART
program size
Facility’s total number of ART visits over number of
non-ART OPD visit as an indicator of relative size of the
ART program in comparison to the non-ART OPD.
ART growth/rate
of scale-up
The annual percent change (year-on-year) in total
ART visits to reflect the pace of ART scale-up in a
given facility.
Wollum et al. BMC Health Services Research  (2017) 17:564 Page 3 of 8
Descriptive results
Between 2007 and 2012, OPD volumes increased at a
majority of facilities across Kenya and Uganda (Fig. 1).
In Kenya, OPD visits increased at 59% of facilities with
ART services and 61% of facilities that did not provide
ART. At the same time, we found larger increases in the
average annual growth of OPD visits in Kenyan facilities
that provided ART services (7·3%) than those that did
not (3·5%). In Uganda, 56% of facilities with ART ser-
vices reported increased OPD growth, while increases
were noted at 73% of health facilities that did not offer
ART services. Contrary to our findings in Kenya, average
annual growth of OPD visits was larger in Ugandan fa-
cilities that did not provide ART services compared to
those that did (11·4% vs. 4.3%).
Looking more specifically at facility type, we found that
in Ugandan hospitals, average annual OPD visits increased
more than three times faster in hospitals that did not pro-
vide ART services (16·5% vs. 4·5%). Faster growth in OPD
visits was also observed among Ugandan health centers that
did not provide ART services (8·0% vs. 3·0%)). In Kenya, a
very different pattern emerged. Average annual OPD visits
increased by 10·3% at hospitals that provided ART services
and 4·1% at those that did not. Interestingly, relatively little
OPD growth was observed at lower-level facilities in Kenya,
irrespective of ART service provision (2·5% average annual
increase among non-ART facilities and 1·8% average annual
decrease among facilities with ART).
ART visits generally increased at a faster pace than OPD
visits. In both Kenya and Uganda, ART visits increased at
an average that exceeded a 10% per year. Health centres
saw a larger average annual increase in ART visits than
hospitals, rising 31·9% and 16·9% per year in Kenya and
Uganda, respectively. For hospitals, we found an average
annual increase of ART visits of 8·7% in Kenya and 12·5%
in Uganda.
Mixed-effects regression results
In assessing the relationship between ART services and
OPD visits at the country level in mixed-effects regres-
sion models, we found that neither the presence, rate of
growth, overall, nor relative size of ART programs had a
statistically significant impact on OPD visits in Kenya or
Uganda (Table 3).
In subgroup analyses based on facility type (hospital and
health centers), we did not find a statistically significant
relationship between ART services and OPD growth in
Kenya (Table 3). This result held true in all four model
Table 2 Facility characteristics by country and facility type
Indicator Kenya Uganda
Hospitals Health centers Hospitals Health centers
ART Non-ART ART Non-ART ART Non-ART ART Non-ART
Facility characteristics
Number of facilities 26 25 25 64 31 22 17 111
Percent urban 81% 96% 52% 38% 81% 91% 29% 21%
Percent publicly owned 77% 20% 84% 50% 55% 9% 88% 70%
Facility physical infrastructure
Functional electricity connection 100% 96% 96% 84% 100% 95% 76% 53%
Improved water source and sanitation 100% 96% 91% 94% 100% 95% 94% 75%
Facility services
On-site lab capability 100% 100% 92% 77% 100% 86% 100% 77%
Outreach program 81% 40% 76% 42% 94% 55% 100% 88%
Human resources (Median and IQR)
Number of medical staff 42 14 10 4 126 11 19 7
(20-137) (8-45) (8-14) (2-7) (95-230) (6-22) (16-27) (4-10)
Patient volumes (Median and IQR)
Non-ART OPD visits per day 69 20 31 12 185 22 52 26
(35-165) (7-42) (16-56) (5-25) (90-346) (13-83) (38-87) (15-46)
ART visits per day 13 - 5 - 25 - 2 -
(2-36) (1-11) (4-102) (<1-6)
ART + non-ART visits per medical staff per day 1.3 1.0 3.7 3.0 1.8 1.8 3.1 3.8
(0.8-2.4) (0.7-1.4) (2.7-5.4) (1.5-5.4) (0.9-2.4) (1.0-4.3) (2.5-4.1) (2.4-6.7)
Values reflect year in which data was collected or the last fiscal year if the variable was collected over the five-year period. Ranges in human resource and patient
volumes are reported within parentheses
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specifications of ART services (presence, growth, overall,
and relative size). In Uganda, subgroup analyses showed
that OPD visits were not statistically significantly affected
by ART clinic growth and size (overall and relative OPD
size). However, while Ugandan health centers did not ap-
pear to be impacted by the presence of an ART program,
hospitals providing ART services were found to have
slower growth in OPD visits compared to those hospitals
that did not provide ART service, equating to an OPD
growth deficit of 34.88 percentage points (95% confidence
interval − 59·54, −10·22; p < 0·01) between the two types
of hospitals.
Discussion
To our knowledge, this is the first study to assess the ef-
fects of facility-based ART programs on trends in OPD
services using nationally-representative facility datasets
in sub-Saharan Africa. On average, we observed substan-
tial increases for both ART and OPD volumes between
2007 to 2012 in both Kenya and Uganda. Furthermore,
we found that the presence, scale-up, and size (overall
and relative to the OPD clinic) of facility-based ART
programs had no statistically significant effects on OPD
visits over time. Overall, our study suggests that facility-
based ART services were introduced and scaled up with-
out having significantly negative effects on OPD volumes
in Kenya and Uganda, a result that supports efforts to
expand ART services in sub-Saharan Africa.
Sub-group analyses examining health centres and hospi-
tals independently in both Kenya and Uganda generally re-
vealed results consistent with the primary analysis across all
health facilities. However, we found that the presence of
Fig. 1 Annual percent change in non-ART OPD and ART visits in Kenya and Uganda. Vertical black lines represent weighted average. Horizontal
colored lines represent interquartile range. Values are not adjusted for any covariates
Table 3 Regression results for the effect of ART program existence and size on the annual rate of change in non-ART OPD visits
ART program measure Kenya
Coefficient (95% confidence interval)
Uganda
Coefficient (95% confidence interval)
Hospitals Health Centers Pooled Hospitals Health Centers Pooled
Presence of ART program 6.14
(−19.69, 31.97)
24.06
(−130.23, 178.36)
6.94
(−56.34, 70.21)
−34.88
(−59.54, −10.22)
42.27
(−255.94, 350.48)
27.93
(−184.78, 240.64)
Percent change in ART visits 0.03
(−0.13, 0.20)
0.03
(−0.18, 0.23)
0.03
(−0.11, 0.16)
0.00
(−0.21, 0.20)
0.17
(−1.73, 2.06)
0.16
(−1.58, 1.91)
Total ART visits (logged) −5.84
(−30.06, 18.37)
−0.03
(−14.79, 14.73)
−2.78
(−14.62, 9.06)
0.43
(−2.28, 3.13)
0.93
(−12.81, 14.67)
0.17
(−5.04, 5.38)
Relative size of ART program −14.83
(−152.74, 123.08)
−14.58
(−33.05, 3.88)
−14.09
(−52.64, 24.45)
−2.47
(−5.24, 0.31)
−40.62
(−193.87, 112.63)
−2.51
(−8.12, 3.11)
Each row shows the coefficients and 95% confidence intervals for a different construct of the independent variable measuring ART services. Results control for
location (urban or rural) and ownership (public or private/NGO). Pooled results also control for type of facility (hospitals or health centers)
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ART services in Ugandan hospitals appeared to negatively
affect OPD growth. The reason for this finding is unclear,
but we do note some potentially important differences be-
tween hospitals in Uganda that provided ART and those
that did not. First, the majority (55%) of hospitals offering
ART services were public, while most non-ART hospitals
were private (91%). This finding is not a surprise given the
way in which ART services were initially rolled out at large
public hospitals throughout Uganda and Kenya, before be-
ing offered in lower level facilities. However, private institu-
tions may have had differential capacities or desire to
expand services given more decentralized decision-making
process [28] and different patient-mixes [29]. Second, non-
ART hospitals were generally smaller than hospitals provid-
ing ART and had small provider to patient ratios (Table 2).
It is possible that the smaller facilities simply had more cap-
acity for growth, and were able to expand at a faster rate
than the larger institutions. Lastly, it is important to con-
sider that other contextual factors may significantly influ-
ence this finding, and the fact that this was noted in only
one of the subgroup analyses suggest that further investiga-
tion is warranted.
Several past studies support our broader findings, offer-
ing a number of explanations as to how ART services ex-
panded without crowding out OPD services. First, many
facilities may have had the slack capacity to accommodate
more patients prior to the introduction and scale-up of
ART, allowing for an influx of additional patients without
substantially straining facility resources [30, 31]. Facility
managers also may have instituted mechanisms for reallo-
cation of resources within facilities, such as task-shifting
among medical staff [5, 32, 33]. Further, the largely vertical
funding and implementation of ART programs may have
shielded other facility resources from being used for ART
[5, 34]. Lastly, HIV-targeted funds may have increased fa-
cility supplies and employed additional medical staff spe-
cifically for ART services, thus preventing a crowd-out of
other types of non-HIV services [9].
Although there has been a large debate on the effect
of ART scale-up and vertical programming on the larger
health system, the majority of published literature asses-
sing the effects of ART services at the facility level sup-
ports our results. Most studies found no significant
deleterious effects on the utilization of non-ART services
with the introduction of ART services, [22, 35] and some
have even shown a positive effect of ART on non-ART
services [23]. Much of the research suggesting a negative
impact of ART programs on the larger health system fo-
cuses on qualitative assessments of health worker migra-
tion from the public to private sector, and analyses of
how funding allocation changed with the increased focus
on HIV/AIDS [8, 16, 18, 20]. However, the impact of
ART services may also vary by the service of interest (i.e.
inpatient, immunization, antenatal care etc.) [15, 21].
Furthermore, different types of HIV services may have
differential effects on non-HIV services, [36] and as we
found here, the impact may also vary by facility-type. Fi-
nally, we should be wary of a possible non-linear rela-
tionship between ART and ODP visits. Currently, many
health facilities in Kenya and Uganda are operating with
low technical efficiency, indicating some slack capacity
that can accommodate ART patients without affecting
the volume of other services [30]. Yet both Uganda and
Kenya recently updated their guidelines to extend ART
eligibility to all people living with HIV, which may sub-
stantially increase the strain on the health system and
begin affecting other types of services [37, 38].
In an era of stagnating DAH for HIV/AIDS, there is
sizeable interest in identifying way for further scaling up
HIV services while continuing to provide and expand non-
HIV services in a complementary manner [30]. This issue
will likely continue to attract attention given the recent up-
date of WHO HIV treatment guidelines, which expand
ART eligibility to all people living with HIV [8]. Experiences
in Kenya and Zambia show that integrating ART with other
health services may be one strategy for supporting contin-
ued growth in patient volumes without a corresponding in-
crease in medical staff [39–41]. However, these experiences
also show that integration alone cannot overcome existing
human resource and infrastructure shortages; instead such
integration can lead to greater occupational stress due to
increased workload for providers and reduced time with
patients [41]. Increased efficiency through improved use of
space and staff time, better teamwork and accountability,
task-shifting, expanded training, and improved patient sat-
isfaction are all strategies that may support continued ART
expansion without negatively impacting existing programs
[20, 39–41]. Going forward, it will be important to monitor
how new models of care alter the relationship between
ART and other services, to both avoid potential strains on
resources and maximize synergies.
The findings of this study should be viewed in light
of some limitations. First, we could not account for
potential shifts in quality of services provided during
the introduction and scale-up of ART. The potential
exists that in order to meet increased patient loads,
less time was spent with patients, and quality of care
suffered [16, 41]. On the other hand, prior studies
demonstrate that service quality can improve amid in-
vestments in laboratories, provider trainings, supply
chains, and facility infrastructure, all of which oc-
curred in Kenya and Uganda during their scale-ups of
ART [16, 42]. Second, record-keeping and data qual-
ity varied substantially by facility, and it is possible
that facilities with ART have benefited from invest-
ments in improved health information systems [43].
However, in comparing rates of data missingness and
entry errors across facilities, we did not find evidence
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of systematic differences between facilities with and
without ART. Finally, we do not truly know what
would have happened to OPD services in the absence
of ART at facilities that provided both services. With-
out this counterfactual, we sought to compare facil-
ities with ART to those without ART. However, it is
possible that facilities without ART fundamentally dif-
fered from facilities with ART. We sought to control
for these differences by including several facility char-
acteristics in our analyses, but we could not account
for every possible factor, such as task shifting and
changes in the catchment population of each facility.
Therefore, some unobserved confounding factors may
remain.
Conclusions
Drawing from a nationally-representative facility data
set in Kenya and Uganda, we found that the presence,
scale-up, overall, and relative size of facility-based ART
programs had no statistically significant impact on
OPD visits. At the national level, we did not observe a
“crowding-out” of OPD services as ART expanded both
within facilities and to new facilities. Recent changes in
ART recommendations may result in an additional in-
flux of patients seeking ART services, and our study
suggests that this may be possible without negatively af-
fecting OPD services. Nonetheless, ongoing monitoring
of facility-specific needs and resource use will be crit-
ical to both improving service provision and minimis-
ing strains to health systems.
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